Brief: Pila Pharma Q2 Operating Loss SEK 2.3 Mln

Pila Pharma AB

26/08/2022 07:37

Aug 26 (Reuters) - Pila Pharma AB  PILA.ST :
    * PILA PHARMA PUBLISHES INTERIM REPORT APRIL 1 - JUNE 30,
2022
    * Q2 REVENUE WAS SEK 651 KSEK (0)
    * Q2 OPERATING LOSS (EBIT) WAS - 2 250 KSEK (- 1 595)
    * Q2 NET LOSS WAS - 6 501 (- 4 797)

Source text for Eikon:  ID:nBQN9LDWFv 
Further company coverage:  PILA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))